165 related articles for article (PubMed ID: 19159229)
1. Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.
Hazra S; Sabini E; Ort S; Konrad M; Lavie A
Biochemistry; 2009 Feb; 48(6):1256-63. PubMed ID: 19159229
[TBL] [Abstract][Full Text] [Related]
2. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
4. Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity.
Iyidogan P; Lutz S
Biochemistry; 2008 Apr; 47(16):4711-20. PubMed ID: 18361501
[TBL] [Abstract][Full Text] [Related]
5. Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Nucleosides Nucleotides; 1999 Aug; 18(8):1883-903. PubMed ID: 10478487
[TBL] [Abstract][Full Text] [Related]
6. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
[TBL] [Abstract][Full Text] [Related]
7. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
8. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
Arnér ES; Spasokoukotskaja T; Eriksson S
Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
[TBL] [Abstract][Full Text] [Related]
9. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1347-1358. PubMed ID: 32189555
[TBL] [Abstract][Full Text] [Related]
10. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
[TBL] [Abstract][Full Text] [Related]
11. Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.
McSorley T; Ort S; Hazra S; Lavie A; Konrad M
FEBS Lett; 2008 Mar; 582(5):720-4. PubMed ID: 18258203
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
[TBL] [Abstract][Full Text] [Related]
14. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase.
Usova EV; Eriksson S
Eur J Biochem; 1997 Sep; 248(3):762-6. PubMed ID: 9342227
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
Beauséjour CM; Gagnon J; Primeau M; Momparler RL
Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
[TBL] [Abstract][Full Text] [Related]
16. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase.
Munch-Petersen B; Piskur J; Sondergaard L
J Biol Chem; 1998 Feb; 273(7):3926-31. PubMed ID: 9461577
[TBL] [Abstract][Full Text] [Related]
17. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
18. siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.
Di Cresce C; Figueredo R; Rytelewski M; Maleki Vareki S; Way C; Ferguson PJ; Vincent MD; Koropatnick J
Oncotarget; 2015 Sep; 6(26):22397-409. PubMed ID: 26087398
[TBL] [Abstract][Full Text] [Related]
19. Two thymidine kinases and one multisubstrate deoxyribonucleoside kinase salvage DNA precursors in Arabidopsis thaliana.
Clausen AR; Girandon L; Ali A; Knecht W; Rozpedowska E; Sandrini MP; Andreasson E; Munch-Petersen B; Piškur J
FEBS J; 2012 Oct; 279(20):3889-97. PubMed ID: 22897443
[TBL] [Abstract][Full Text] [Related]
20. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
Nielsen SE; Munch-Petersen B; Mejer J
Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
